TD139

· Galecto Biotech AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TD139, covering 2021-04-08 to 2021-04-08. Get the full timeline:

Most recent: Clinical Trial Update: RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients [Phase 1, Phase 2]